Results for "HDA Factbook"
Healthcare Distributors Playing Central Role As COVID-19 Vaccination Campaign Accelerates
We have reached another pivotal moment in the fight against COVID-19: the Food and Drug Administration (FDA) has authorized Johnson & Johnson’s COVID-19 vaccine candidate for emergency use. With demand for vaccines currently outpacing supply, the addition of a third candidate is welcome news for Americans. Most importantly, a one-dose option that only requires refrigeration will provide greater flexibility in delivering vaccines to more individuals, including those in underserved and rural areas, with the ability to scale up production exponentially as we move into the spring and summer months.
Value Drug Helps Pharmacies During COVID-19
Every day, pharmacists are on the frontlines of patient care — providing information and resources, valuable face-to-face counseling as well as dispensing the medicines that patients need to manage their health and well-being. During COVID-19, pharmacists’ role as counselors, educators and advocates to patients has never been more critical.
The First 90 Days of COVID-19: Lessons Learned
The emergence of COVID-19 marked the beginning of a public health crisis the scale of which we have never seen. Amid this unprecedented challenge, the pharmaceutical supply chain — powered by distributors — quickly adapted and adjusted to the global pandemic, protecting the steady supply of critical, lifesaving medicines to hospitals, pharmacies, providers and patients.
BluPax Pharma Celebrates 10 Years of Effective Relationship Building
For HDA member BluPax Pharma, an independently owned and operated distributor of generic pharmaceuticals, relationships are at the core of everything they do.